Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study-Reference-Cited by-同舟云学术

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

Published:2020-05 Issue:10238 Volume:395 Page:1705-1714
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

de Abajo Francisco J,Rodríguez-Martín Sara,Lerma Victoria,Mejía-Abril Gina,Aguilar Mónica,García-Luque Amelia,Laredo Leonor,Laosa Olga,Centeno-Soto Gustavo A,Ángeles Gálvez Maria,Puerro Miguel,González-Rojano Esperanza,Pedraza Laura,de Pablo Itziar,Abad-Santos Francisco,Rodríguez-Mañas Leocadio,Gil Miguel,Tobías Aurelio,Rodríguez-Miguel Antonio,Rodríguez-Puyol Diego,Barreira-Hernandez D,Zubiaur P,Santos-Molina E,Pintos-Sánchez E,Navares-Gómez M,Aparicio R M,García-Rosado V,Gutiérrez-Ortega C,Pérez C,Ascaso A,Elvira C

Funder

Institute of Health Carlos III

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus;Wan;J Virol,2020

2. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases;Li;Pharmacol Res,2017

3. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2;Ferrario;Circulation,2005

4. Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rats;Ocaranza;Hypertension,2006

5. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan;Soler;Am J Physiol Renal Physiol,2009

Cited by 335 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between renin‐angiotensin antagonism and COVID‐19–related mortality in patients with essential hypertension: A single center, retrospective cohort study;The Journal of Clinical Hypertension;2024-07-14

2. Features of the Course of Arterial Hypertension in the Era of the COVID-19 Pandemic: Common Pathogenetic Links Between Hypertension and SARS-CoV-2;Kardiologiia;2024-04-30

3. Role of the RAAS in mediating the pathophysiology of COVID-19;Pharmacological Reports;2024-04-23

4. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient;Inflammopharmacology;2024-04-15

5. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction;Journal of the American College of Cardiology;2024-04